Allurion device
WebOct 28, 2024 · Allurion has secured approval from Brazilian Health Regulatory Agency ANVISA to launch its gastric balloon technology in the country. Known as the Elipse Balloon in Brazil, it is claimed to be the first and only intragastric weight-loss balloon in the world. It can be placed and removed without the need for surgery, endoscopy or anaesthesia. WebAllurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy. Wellesley, Massachusetts, United States 51-100 Series D Private allurion.com 5,668 Highlights Total Funding Amount $150.2M Contacts 49 Employee Profiles 2 Investors 10 Similar Companies 6
Allurion device
Did you know?
WebApr 5, 2024 · The Allurion Program is a 360-degree weight loss experience featuring the Allurion Gastric Balloon, the world’s first and only swallowable, procedureless gastric balloon for weight loss, the... WebDec 9, 2015 · The device is for use in a combination with a comprehensive weight loss program, the company said. ... Allurion reported average weight loss of 22 pounds, with …
WebWhether you’re planning to get rid of baby weight or simply change your lifestyle, the Allurion Program offers the support you need throughout your weight lo... WebThe Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients …
WebNov 24, 2024 · Allurion (formerly known as Elipse) is an intragastric balloon that’s swallowed and then filled with a saline solution so it takes up space in your stomach, … WebApr 8, 2024 · The Allurion Program is a 360-degree weight loss experience featuring the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for clinicians featuring the Iris AI Platform, and the …
WebAllurion Technologies is one step closer to having its Elipse gastric balloon enter the US market, after company announced the PMA submission of the device to the FDA. The submission comes after Allurion raised US$34 million in new funding through a securities financing and a growth capital term loan.
WebThe Allurion Gastric Balloon is suitable for people with a BMI of 27 and above. Research shows an average total body weight loss of 10-15% after 4 months on the Allurion Programme.12 However, people with a higher BMI of 35 or more tend to lose an average of 15% after 4 months. Additional weight loss – on average 23% of total body weight ... asia 54 tramWebMar 16, 2024 · Allurion Technologies is a medical device company headquartered in Natick, Massachusetts. Founded in 2009, this company manufactures and markets the Elipse Balloon, an innovative weight loss therapy for overweight and obese individuals. Industry. Medical Devices & Equipment Manufacturing . asia 54 tram tu thiengWebNov 3, 2024 · Allurion is the first gastric balloon that requires no endoscopy* or anesthesia for placement or removal. Simply swallow a capsule containing the deflated Balloon with … asia 52WebMay 10, 2024 · The AGBS is designed to promote weight loss in individuals with obesity. The AGBS includes the Allurion Balloon, which is a temporary gastric balloon that … asia5 aeatWebJul 6, 2024 · Allurion Insights, offering providers real-time patient analytics and telehealth features The Allurion Balloon is the world’s first and only procedureless™ medical device for weight loss that... asia 54 menuWebAbout. About me: • Highly motivated and data-driven engineer who loves to solve the most challenging problems in the medical device industry. • … asia5b sdn bhdWebFeb 9, 2024 · Allurion has created the world’s first full stack weight-loss platform featuring the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight... asia 5 tmk